Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis
Abstract Background Postpartum depression (PPD) is categorized by the Disorders-Fifth Edition as depression that begins during pregnancy or within the first month after giving birth. Ketamine and esketamine have shown promising results in the treatment of several depressive disorders, which suggests...
Saved in:
| Main Authors: | Moaz Yasser Darwish, Abdallah A. Helal, Yousif Ahmed Othman, Manar Alaa Mabrouk, Aya Alrawi, Taha Abd-ElSalam Ashraf, Nada K. Abdelsattar, Fatma Mohammed Sayed, Mohamed Abd-ElGawad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Pregnancy and Childbirth |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12884-025-07186-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perioperative use of esketamine for the prevention of postpartum depression after cesarean section: a meta-analysis
by: Yanhong Li, et al.
Published: (2025-07-01) -
Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms
by: Piotr Kawczak, et al.
Published: (2024-10-01) -
Ketamine in Prevention and Treatment of Postpartum Depression - Literature Review
by: Daria Stefaniak, et al.
Published: (2025-03-01) -
Effect of ketamine and esketamine on RNA expression and its relevance for depression: A systematic review
by: Claudia Pisanu, et al.
Published: (2025-09-01) -
Efficacy and safety of ketamine and esketamine for preventing opioid-induced cough: a systematic review and meta-analysis of randomized controlled trials
by: Kuo-Chuan Hung, et al.
Published: (2025-07-01)